¿La eficacia y seguridad de las heparinas de bajo peso molecular (HBPM) dependen de la actividad anti-FXa y anti-FIIa? Otras actividades antitrombóticas de las HBPM / Do the efficacy and safety of low molecular weight heparins (LMWH) depend on the anti-Fxa and anti-FIIa activity? Other antithombotic activities of the LMWH
Rev. iberoam. trombos. hemost. (Ed. impr.)
; 13(2): 63-68, jun. 2000. tab
Article
in ES
| IBECS
| ID: ibc-15559
Responsible library:
ES1.1
Localization: ES1.1 - BNCS
RESUMEN
No disponible
Search on Google
Collection:
National databases
/
Spain
Health context:
SDG3 - Health and Well-Being
Health problem:
Target 3.4: Reduce premature mortality due to noncommunicable diseases
Database:
IBECS
Main subject:
Prothrombin
/
Factor Xa
/
Antithrombin III
/
Heparin, Low-Molecular-Weight
/
Anticoagulants
Type of study:
Etiology study
Limits:
Humans
Language:
Spanish
Journal:
Rev. iberoam. trombos. hemost. (Ed. impr.)
Year:
2000
Document type:
Article
Institution/Affiliation country:
Ciudad Sanitaria y Universidad de Bellvitge/España